Effects of Three-Month Intake of Synbiotic on Inflammation and Body Composition in the Elderly: A Pilot Study by Valentini Neto, Joao et al.
Nutrients 2013, 5, 1276-1286; doi:10.3390/nu5041276 
 
nutrients 
ISSN 2072-6643 
www.mdpi.com/journal/nutrients 
Article 
Effects of Three-Month Intake of Synbiotic on Inflammation 
and Body Composition in the Elderly: A Pilot Study 
João Valentini Neto 
1
, Camila Maria de Melo 
2
 and Sandra Maria Lima Ribeiro 
1,
* 
1
 School of Arts, Sciences and Humanities, University of São Paulo, São Paulo, CEP 03828-000, 
Brazil; E-Mail: joaovneto@gmail.com 
2
 Federal University of São Paulo, São Paulo, CEP 04020-050, Brazil;  
E-Mail: cami_maria4@hotmail.com 
* Author to whom correspondence should be addressed; E-Mail: smlribeiro@usp.br;  
Tel.: +55-11-3091-8866; Fax: +55-11-2645-9526. 
Received: 15 January 2013; in revised form: 25 February 2013 / Accepted: 25 March 2013 / 
Published: 17 April 2013 
 
Abstract: We hypothesize that improvements in the gut microbiota are capable of 
ameliorating gut permeability and, consequently, reducing systemic inflammation and the 
risk of frailty. This study aims to evaluate some effects of synbiotic supplementation on 
inflammatory markers and the body composition of the elderly at risk of frailty. In a  
double-blind study that lasted three months, 17 elderly individuals fulfilling one frailty 
criteria (grip strength) were randomly distributed into two groups: SYN (n = 9), daily 
intake of synbiotic (6 g Frutooligossacarides, 10
8
 to 10
9
 CFU Lactobacillus paracasei,  
10
8
 to 10
9
 CFU Lactobacillus rhamnosus, 10
8
 to 10
9
 CFU Lactobacillus acidophilus and 
10
8
 to 10
9
 CFU Bifidobacterium lactis), or placebo (maltodextrin; PLA; n = 8). Subjects 
were analyzed for anthropometric measurements, bioelectric impedance with vectorial 
analysis (BIVA), IL-6 and TNF-α. A comparison between groups did not show any 
difference for the variables investigated. In turn, individual analysis of electrical 
impedance (BIVA) demonstrated that the majority of SYN individuals maintained or 
improved their tissue hydration, when compared to the PLA group after supplementation. 
In conclusion, three months of synbiotic supplementation did not promote any significant 
changes in inflammatory cytokines or body composition, but demonstrated a trend towards 
a preservation of hydration status in apparently healthy elderly individuals. 
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1. Introduction 
Aging results in alterations in body functions, leading to consequences such as the reduction in  
fat-free mass (FFM). FFM, besides its structural role, is fundamental for the mobilization of metabolic 
substrates and for essential molecules synthesis, amongst other mechanisms [1,2]. In addition, skeletal 
muscle is the main source of body protein, and is capable of driving antibody production, wound 
healing and white blood cell production during acute or chronic diseases [3–5]. Therefore, if lean mass 
is depleted, there is less protein to support the body’s functionality, enhancing the risk of disabilities, 
reducing muscle power and/or physical function, increasing the risk of developing frailty  
syndrome [6]. Based on this evidence, investigations have tried to identify the origin of sarcopenia, a 
component of frailty syndrome, in order to prevent it or to reduce its consequences. 
There are a number of physiological, metabolic, genetic and lifestyle factors that can favor the 
development of sarcopenia. Among these factors, low-grade systemic inflammation is considered to be 
important; low-grade inflammation associated with aging has been named, by some authors, as 
inflammaging [7], and is shown to have a complex integration with different body tissues/systems and 
somato senescence. Adipose tissue, gut and its microbiota have been implicated in the development of 
low-grade systemic inflammation in aging [8–10]. Changes in the gastrointestinal tract, as well as 
modifications in the diet and host immune system, affect the gut microbiota [8–10], for instance, 
increasing gram-negative bacteria (mainly Enterobaceria) and reducing Lactobacilus [9,11]. In turn, 
an imbalance in gut microbiota can modify gut permeability, which allows some of its content 
(bacteria and/or bacteria fragments, particularly the Gram-negative-derived lipopolysaccharides, LPSs) 
to pass through the gut wall towards the circulation, which is termed metabolic endotoxemia [12,13]. 
These molecules reach specific receptors (i.e., toll-like receptor-TLR-4), in the adipose tissue and 
muscle tissue, among others, stimulating macrophage infiltration and activating the synthesis of 
inflammatory cytokines. This condition can contribute to outcomes such as reduced insulin sensitivity 
and sarcopenic obesity [8,9,12,14]. In skeletal muscle, cytokine signaling can result in enhanced 
catabolism and inhibit protein synthesis, modifying contractibility and muscle function as a 
consequence [9,15]. 
As such, we hypothesize that improvements in gut microbiota are capable of ameliorating gut 
permeability, therefore reducing systemic inflammation and its consequences. One strategy for 
improving the gut environment is the intake of prebiotic, probiotic or synbiotic substances, alone or in 
combination with food [16,17]. In brief, probiotics are “live microorganisms which when administered 
in adequate amounts confer a health benefit on the host” [18]. Prebiotics are “nondigestible food 
ingredients that, when consumed in sufficient amounts, selectively stimulate the growth and/or activity 
of one or a limited number of microbes in the colon, resulting in documented health benefits” [19].  
A synbiotic is a combination of prebiotic and probiotic substances [20]. A number of studies have 
shown benefits of the intake of these substances in the management of diseases associated with 
systemic inflammation [21,22]. 
Considering that sarcopenia is an important manifestation of aging, with health and economic 
consequences, the present study aimed to evaluate the effects of the intake of a synbiotic substance on 
systemic low-grade inflammation and body composition in elderly individuals with a risk of frailty. 
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2. Experimental Section 
2.1. Volunteer Recruitment and Ethical Aspects 
The experiment included a convenience, non-probabilistic sample and was conducted from January 
to August 2010. All the volunteers participated simultaneously; the recruitment was made at January 
and February, the experiment was performed from March to May, and the results analysis was made 
from June to August. Volunteers were community-dwelling elderly, recruited from three different 
institutions and/or associations: an open university for older individuals, a recreational association and 
a physiotherapy center. The researchers extended a general invitation at these locations, and the 
subjects who were willing to take part in the experiment were checked for their eligibility. To be 
included, the participants had to be between 60 and 75 years old, free-living, and had to fulfill one of 
the frailty criteria proposed by Fried et al. [3]: the handgrip strength. As exclusion criteria, subjects 
should not report, at least three months prior the experiment, acute or chronic inflammatory gut 
diseases, use antibiotics, prebiotic, probiotic or synbiotic substances, or use of laxatives or anti-diarrhea 
medication. All the procedures were explained to the participants, who signed their informed consent. 
The project was approved by the local ethics committee (São Judas Tadeu University, COEP, São 
Paulo, SP, Brazil), protocol number 010/2010.  
2.2. Study Design 
The volunteers were randomly distributed into two groups, in a double-blind experiment, lasting 
three months. One group (SYN) received one daily dose of a commercially available synbiotic substance, 
registered by the Brazilian Agency of Sanitary Surveillance-ANVISA (6 g Frutooligossacarides,  
10
8
 to 10
9
 CFU Lactobacillus paracasei, 10
8
 to 10
9
 CFU Lactobacillus rhamnosus, 10
8
 to 10
9
 CFU 
Lactobacillus acidophilus and 10
8
 to 10
9
 CFU Bifidobacterium lactis). The PLA group ingested a 
placebo (maltodextrin). Randomization was performed by a colleague that was not taking a direct part 
in the study. Using a sheet with the names of the participants, the names were manually sorted out into 
groups, and from that time onward each were identified by a number. The same colleague organized 
the closed packages containing the powder to be ingested (placebo or synbiotics), labeling the packages 
with the numbers. The packages were similar for both groups, and the substances did not differ in color 
or flavor. The names of the subjects were revealed to the researchers only after the end of the experiments. 
The subjects were instructed to dilute the powder in water and to drink the entire content of the 
resulting liquid following the last meal of the day. In addition, the participants were advised to not 
modify their daily habits; including meal times. To ensure that food and drink ingestion were not 
modified during the experiment; the participants were instructed to record daily food diaries; which 
were checked weekly during phone calls from the researchers. During these phone calls the researchers 
also checked whether the supplement was consumed correctly; and discussed any side effects. 
2.3. Variables Investigated Before and after Three Months of Supplementation 
Grip strength, which was one of the inclusion criteria, was evaluated with a dynamometer (Kratos 
Equipments
®
). The cutoff points to include the individuals in the study followed the recommendations 
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of the American Society of Hand Therapists [23], which was proposed by Fried et al. [3]. Body mass 
(Filizola
®
 scale with 0.1 g precision) and height (Secca
®
 stadiometer to the nearest 0.1 cm) were 
evaluated to calculate the body mass index (BMI, kg/m
2
). In addition, skin fold measurements were 
taken from the triceps, subscapular, suprailiac, abdominal and calf (Lange
®
 caliper). Waist, hip and calf 
circumferences were also measured. The anthropometric procedures were based on Lohman, Roche & 
Martorell [24] and the measurements were always performed by the same experienced researcher. 
Bioelectrical impedance analysis (BIA) was carried out after an overnight fast. BIA (Biodynamics 
450e
®
) was performed while the participants were in a supine position and on a non-conductive 
surface, with the electrodes placed on the recommended locations on the hands and feet. The data were 
analyzed for resistance (R) and reactance (Xc), and plotted on an R/ht Xc/ht graph (vectorial  
analysis-BIVA). To plot the graphs, BIVA software was utilized (Department of Medical and Surgical 
Sciences, University of Padova, Padova, Italy, 2002) [25–27]. In addition, from the measurements of 
resistance and reactance, the fat mass and fat free mass were estimated, according to the equations 
provided by the equipment’s manufacturer [28]. 
Blood samples were collected after an overnight fast. After centrifugation, plasma was collected 
and stored for the analysis of IL-6 and TNF-α by ELISA (Diasource kits CAT# KP1261 sensibility  
2 pg/mL and CAT#KAP1751, sensibility 0.7 pg/mL, respectively).  
2.4. Data Analysis 
All the statistical analyses were conducted by the researchers, under the supervision of an 
experienced statistician. Levene’s test showed a normal distribution of all the variables investigated. 
Groups were compared by repeated measures ANOVA, followed by the LSD post-hoc test, using 
Statistica software, 11 (StatSoft, 1984-2012
®
). The BIA vector analysis was performed with BIVA 
software (Department of Medical and Surgical Sciences, University of Padova, Padova, Italy, 2002). 
An acceptable level of significance was established as p < 0.05 for all the analyses performed.  
3. Results 
Forty two individuals volunteered for the study. Of these, 25 did not fulfill the inclusion criteria, 
and 18 of these attended the initial evaluation; one of these individuals interrupted the treatment, due 
to personal reasons not related to the side effects of the supplement. Therefore, 17 participants, of both 
genders (8 PLA (5 women and 3 men) and 9 SYN (8 women and one man)) concluded the study. 
During the final evaluation (post-supplementation), one subject, allocated to the PLA group, and one 
subject allocated to the SYN group did not perform the BIA analysis, due to technical problems. As 
such, for the BIA analysis, the sample was composed of 7 PLA and 8 SYN individuals. The mean age 
of the participants was 67.9 ± 4.5 years old (range 60–74 years). 
Table 1 describes anthropometric, BIA and grip strength measurements. There were a small number 
of variables that presented significant differences (body mass, subscapular skin fold, suprailiac skin 
fold), between groups or between the time points. 
Figure 1 reports inflammatory cytokine concentrations before and after the experiment. The values 
did not differ either between groups or between the time points. 
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Table 1. Variables evaluated before and after the supplementation. 
Variable 
PLA SYN 
Initial (n = 8) Final (n = 8) Initial (n = 9) Final (n = 9) 
Anthropometric measurements  
BM (Kg) 69.6 ± 22.6 * 73.5 ± 22.6 * 64.9 ± 13.6 64.3 ± 13.7 
BMI (Kg/m
2
) 28.5 ± 6.5 30.3 ± 6.4 27.9 ± 6.9 28.1 ± 7.1 
TSF (mm) 21.0 ± 7.2 22.8 ± 4.4 17.3 ± 7.3 17.0 ± 7.1 
SsSK (mm) 20.4 ± 4.2 22.5 ± 3.1 16.4 ± 6.5 * 17.9 ± 7.3 * 
BSF (mm) 14.1 ± 7.0 16.4 ± 5.4 10.2 ± 5.5 10.3 ± 5.5 
SiSF (mm) 19.7 ± 5.4 * 24.7 ± 3.4 *
,a
 15.4 ± 8.1 15.4 ± 9.2 
a
 
AbSF (mm) 26.0 ± 5.4 28.0 ± 3.6 21.9 ± 9.1 22.6 ± 8.6 
CSF (mm) 21.9 ± 11.0 21.1 ± 8.9 17.1 ± 8.3 18.0 ± 8.3 
WC (cm) 98.8 ± 18.3 100.5 ± 16.4 94.8 ± 15.7 93.3 ± 15.3 
HC (cm) 101.6 ± 11.0 102.5 ± 8.7 101.4 ± 9.3 101.3 ± 9.7 
CC (cm) 37.9 ± 5.3 39.0 ± 5.0 37.5 ± 6.1 37.4 ± 5.7 
BIA measurements 
R/Ht (Ω/m) 358.3 ± 57.0 358.6 ± 79.8 ## 368.0 ± 73.4 377.3 ± 67.0 # 
Xc/Ht (Ω/m) 31.2 ± 9.7 34.7 ± 9.9 ## 32.7 ± 9.5 31.5 ± 7.7 # 
BIA estimation of body composition 
% BF 36.0 ± 7.0 38.6 ± 6.4 
##
 35.6 ± 10.0 36.2 ± 10.7 
#
 
FM (Kg) 26.2 ± 13.3 29.3 ± 13.9 
##
 23.9 ± 10.1 24.1 ± 10.5 
#
 
FFM (kg) 43.6 ± 10.6 44.4 ± 11.7 
##
 41.0 ± 6.9 40.2 ± 6.5 
#
 
Dinamometer measurements 
Grip Strength (N) 15.9 ± 2.7 17.2 ± 3.9 15.0 ± 5.2 15.7 ± 5.3 
#
 n = 8; 
##
 n = 7; * significant difference between pre and post values (p < 0.05); 
a
, significant difference 
between placebo and synbiotic at post values (p < 0.05); ANOVA for repeated measures; TSF, triceps 
skinfold; SsSF, subscapular skinfold; BSF, biceps skinfold; SiSF, suprailiac skinfold; AbSF, abdominal 
skinfold; CSF, calf skinfold; WC, waist circumference; HC, hip circumference; CC, calf circumference; 
R/Ht, resistance divided by height; Xc/H, reactance divided by height; %BF, percentage of body fat; FM, fat 
mass; FFM, fat free mass. 
Figure 1. Cytokine concentration before (white columns) and after (green columns) 
supplementation. (A) IL-6; (B) TNF-α. Group 1 = PLA (n = 8); Group 2 = SYN (n = 9). 
Repeated measures ANOVA. 
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Figure 2A,B shows the BIVA analysis from the RXc path graphs, which demonstrate vector 
migration, from before and after supplementation, for both groups. It is important to notice that the 
figures show individual vector migration. Therefore, this information does not demand statistical 
analysis of the group, and do not allow to point which group improved or which group jeopardized the 
hydration status. However, it is possible to highlight some information from these individual graphics. 
For the PLA group (A), 6 out of 7 participants (individuals 2–7, totaling 85.7% of the group) 
demonstrated a trend for vectors migrating towards dehydration (vectors migrated towards the upper 
pole), and therefore, only one individual (individual 1, totaling 14.3%) showed enhanced tissue 
hydration (vector migrated towards the bottom pole). For the SYN group (B), 5 out of 8 participants 
demonstrated vectors that pointed towards maintenance (individuals 7 and 8) or better hydration 
(individuals 1, 2 and 5), totaling 62.5%, and 3 individuals (individuals 3, 4, and 6, totaling 37.5%) 
demonstrated migration towards lower hydration. Summarizing, the majority of the individuals 
allocated in PLA group had their vectors toward dehydration, whilst the majority of the individuals at 
SYN group maintained or improved their hydration status. 
Figure 2. R/Xc path graph of vector migration. (A) PLA group (n = 7) and (B) SYN group 
(n = 8). The vectors were plotted on the reference 50th, 75th, and 95th tolerance ellipses of 
a reference healthy population. The path graph starts with an arrow from the origin  
((0.0) point in the graph). When observing the arrow, the first point is the initial value and 
the second is the final value. To understand the meaning of vector migration, the major 
axis refers to hydration status (dehydrated individuals tending towards the upper pole). 
BIVA software (Department of Medical and Surgical Sciences, University of Padova, 
Padova, Italy, 2002). 
A 
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Figure 2. Cont. 
B 
 
4. Discussion 
We hypothesized that synbiotic supplementation could present benefits to the elderly, keeping in 
mind the following sequence of events: improvement in gut microbiota, reduction in systemic 
inflammation, and slowdown of fat-free mass reduction. Our randomized study, considering our 
experimental conditions, did not suggest any expressive advantage for synbiotic supplementation. The 
great majority of the data analyzed did not show significant differences, either between groups or 
between time points. 
Despite the lack of significance between groups for the majority of the analyses, individual BIVA 
results suggested some trends. The majority of the volunteers allocated to the PLA group 
demonstrated, at the end of the experiment, a migration of their vectors towards dehydration, and this 
fact was not observed in the majority of individuals allocated to the SYN group. These very subtle 
trends could indicate, in the PLA group, some water imbalance. It is important to remember that we 
analyzed the inflammatory cytokine concentration, together with BIVA (an indirect investigation of 
tissue hydration); during inflammation, variables associated with capillary permeability are modified, 
causing changes in colloid-osmotic pressure as well as in plasma and interstitial fluid pressure. These 
changes result in a water imbalance [29], and could interfere in processes such as protein  
synthesis [29–31]. Therefore, protein synthesis (and consequently the improvement and/or 
maintenance of muscle mass) starts with a good water balance in the muscle fiber environment [32]. 
It is interesting to note that the PLA group, besides presenting a trend towards lower hydration, 
demonstrated an enhancement in body weight and suprailiac skin fold. We may assume from these 
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data, that the PLA group presented a slightly higher adiposity. It is known that the higher the adiposity, 
the lower the hydration [33], and therefore we can hypothesize that as SYN supplementation 
maintained the hydration status, it impaired or reduced fat gain. We must remember that fat gain is 
very common during the aging process, and is one of the factors associated with sarcopenic  
obesity [31]. However, it is important to bear in mind that anthropometric measurements have to be 
analyzed as a whole, and most of the measurements made did not present significant differences. 
Additionally, the concentration of inflammatory cytokines did not support our hypothesis (considering 
the sequence: gut microbiota, gut permeability, inflammation and muscle mass). 
Probably one difficulty in finding differences between groups in the present study was the 
recruitment of supposedly healthy (free-living) elderly. It is important to remember that during the 
aging process, even in non-pathological situations, a reduction in body water (and therefore in FFM) 
has been observed both in men and women [32]. These reductions are expected to be very slow and 
subtle and may justify the absence of significant differences in our study. In fact, for this reason, we 
investigated the “reduction in losses”, rather than “enhancement” in fat-free mass. As such, we can 
infer that a longer time of supplementation may be necessary. Additionally, for further studies, 
considering the hypothesis that the gut is one of the main sites responsible for the beginning of  
low-grade inflammation in the elderly, the measurement of variables associated with the gut 
permeability may be more sensitive to the possible effects of synbiotic supplementation (for instance, 
LPS). Therefore, the main limitations of our study are: the small sample size (which is a very frequent 
problem in studies with the elderly), the short time for supplementation and the lack of more specific 
markers of gut permeability. It is important to highlight that we cannot generalize our results, 
principally due to the existence of individual, regional or national differences in gut microbiota.  
5. Conclusion 
According to our experimental conditions, three months of synbiotic supplementation did not 
promote significant differences in variables related to inflammation or body composition in the elderly. 
However, we observed a subtle trend towards an improved hydration status, which could signify, in the 
long term, benefits for the FFM. Sarcopenic processes should be monitored, due to their relationship 
with outcomes such as frailty and, therefore, further experiments of longer duration, with the 
measurement of specific markers of gut permeability and inflammation, should clarify our hypotheses. 
We believe that systemic inflammation reductions, as well as changes in fat free mass, demand longer 
than three months to be identified from biomarkers such as cytokines, LPS or even body  
composition method.  
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